» Articles » PMID: 35957142

Fullerene Derivatives for Drug Delivery Against COVID-19: A Molecular Dynamics Investigation of Dendro[60]fullerene As Nanocarrier of Molnupiravir

Overview
Date 2022 Aug 12
PMID 35957142
Authors
Affiliations
Soon will be listed here.
Abstract

In this paper, a theoretical investigation is made regarding the possibility of using a water-soluble derivative of C as a drug delivery agent for treating Coronavirus disease 2019 (COVID-19). Molnupiravir is chosen as the transporting pharmaceutical compound since it has already proved to be very helpful in saving lives in case of hospitalization. According to the proposed formulation, a carboxyfullerene known as dendro[60]fullerene is externally connected with two molnupiravir molecules. Two properly formed nitrogen single bonds (N-N) are used as linkers between the dendro[60]fullerene and the two molnupiravir molecules to create the final form of the C derivate/molnupiravir conjugate. The energetics of the developed molecular system and its interaction with water and n-octanol are extensively studied via classical molecular dynamics (MD) using the COMPASS II force field. To study the interactions with water and n-octanol, an appropriate periodic amorphous unit cell is created that contains a single C derivative/molnupiravir system surrounded by numerous solvent molecules and simulated via MD in room conditions. In addition, the corresponding solvation-free energies of the investigated drug delivery system are computed and set in contrast with the corresponding properties of the water-soluble dendro[60]fullerene, to test its solubility capabilities.

Citing Articles

Integrating computational insights in gold nanoparticle-mediated drug delivery: enhancing efficacy and precision.

Alalmaie A, Alshahrani H, Alqahtani M, Alshahrani Z, Alahmari S, Asiri A Front Med Technol. 2025; 7:1528826.

PMID: 40066057 PMC: 11892449. DOI: 10.3389/fmedt.2025.1528826.


Smart drug delivery: a DFT study of C fullerene and doped analogs for pyrazinamide.

Moumivand A, Naderi F, Moradi O, Makiabadi B Nanoscale Adv. 2025; 7(5):1287-1299.

PMID: 39802333 PMC: 11712202. DOI: 10.1039/d4na00560k.


A Comparative DFT Investigation of the Adsorption of Temozolomide Anticancer Drug over Beryllium Oxide and Boron Nitride Nanocarriers.

Ibrahim M, Rady A, Sidhom P, Sayed S, Ibrahim K, Awad A ACS Omega. 2024; 9(23):25203-25214.

PMID: 38882172 PMC: 11170632. DOI: 10.1021/acsomega.4c02882.


Inorganic nanoparticle-cored dendrimers for biomedical applications: A review.

Fateh S, Aghaii A, Aminzade Z, Shahriari E, Roohpour N, Koosha F Heliyon. 2024; 10(9):e29726.

PMID: 38694058 PMC: 11061704. DOI: 10.1016/j.heliyon.2024.e29726.


DFT investigation of temozolomide drug delivery by pure and boron doped C fullerene-like nanocages.

Tamafo Fouegue A, de Paul Zoua V, Kounou G, Ndjopme Wandji B, Ghogomu J, Ntieche R Nanoscale Adv. 2023; 5(21):5880-5891.

PMID: 37881702 PMC: 10597570. DOI: 10.1039/d3na00402c.


References
1.
Lurie N, Saville M, Hatchett R, Halton J . Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. 2020; 382(21):1969-1973. DOI: 10.1056/NEJMp2005630. View

2.
Hurmach V, Platonov M, Prylutska S, Scharff P, Prylutskyy Y, Ritter U . C fullerene against SARS-CoV-2 coronavirus: an in silico insight. Sci Rep. 2021; 11(1):17748. PMC: 8423725. DOI: 10.1038/s41598-021-97268-6. View

3.
Kabinger F, Stiller C, Schmitzova J, Dienemann C, Kokic G, Hillen H . Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol. 2021; 28(9):740-746. PMC: 8437801. DOI: 10.1038/s41594-021-00651-0. View

4.
Ghaemi F, Amiri A, Bajuri M, Yuhana N, Ferrara M . Role of different types of nanomaterials against diagnosis, prevention and therapy of COVID-19. Sustain Cities Soc. 2021; 72:103046. PMC: 8146202. DOI: 10.1016/j.scs.2021.103046. View

5.
Polidoro R, Hagan R, Santiago R, Schmidt N . Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Front Immunol. 2020; 11:1626. PMC: 7344249. DOI: 10.3389/fimmu.2020.01626. View